Package 72603-122-01

Brand: topiramate

Generic: topiramate
NDC Package

Package Facts

Identity

Package NDC 72603-122-01
Digits Only 7260312201
Product NDC 72603-122
Product ID 72603-122_912c8dcf-d2d0-4e95-831f-3e672f285aef
Description

30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-122-01)

Marketing

Marketing Status
Marketed Since 2023-01-01
Brand topiramate
Generic topiramate
Sample Package No

Linked Drug Pages (1)

TOPIRAMATE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "912c8dcf-d2d0-4e95-831f-3e672f285aef", "openfda": {"nui": ["N0000008486", "N0000185506", "N0000182140"], "upc": ["0372603120011", "0372603123012", "0372603122015", "0372603121018", "0372603124019"], "unii": ["0H73WJJ391"], "rxcui": ["1494769", "1812419", "1812421", "1812425", "1812427"], "spl_set_id": ["b5f8da43-6daf-413c-9dcd-363617973738"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_moa": ["Cytochrome P450 3A4 Inducers [MoA]", "Cytochrome P450 2C19 Inhibitors [MoA]"], "manufacturer_name": ["NorthStar RxLLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-122-01)", "package_ndc": "72603-122-01", "marketing_start_date": "20230101"}], "brand_name": "TOPIRAMATE", "product_id": "72603-122_912c8dcf-d2d0-4e95-831f-3e672f285aef", "dosage_form": "CAPSULE, EXTENDED RELEASE", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "72603-122", "generic_name": "topiramate", "labeler_name": "NorthStar RxLLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "TOPIRAMATE", "active_ingredients": [{"name": "TOPIRAMATE", "strength": "100 mg/1"}], "application_number": "ANDA210278", "marketing_category": "ANDA", "marketing_start_date": "20230101", "listing_expiration_date": "20261231"}